Triple-negative breast cancer (TNBC) is a subtype of breast cancer that lacks expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) 1. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.